Stifel ups Equasens to 'buy' on expected rebound, shares rise
03/06/2024 09:35
** Shares of French healthcare IT solutions provider
Equasens EQSE.PA rise 8% after Stifel ups rating to "buy" from
"hold" on expected rebound in growth from this year and
attractive valuation
** Group looks set for strong rebound in H2 2024 and 2025
with better end-market momentum, growing sales, new product
launches and investments as well as expansion in Italy and
Germany - Stifel
** Equasens also consistently outperforms peers on
profitability, cash generation - Stifel
** Notes cash-rich group has more M&A firepower than ever
and has been prioritising investments in markets where it has an
edge
** With valuation at near 10-year lows, "we believe it is a
great opportunity to invest in a low-risk long-term high-quality
company - Stifel
** Adds, Equasens' share price has potential to double over
the next five years
(Reporting by Dagmarah Mackos)
((dagmarah.mackos@tr.com))